Literature DB >> 22261560

Phenotypic variation of autosomal-dominant corticobasal degeneration.

Hans H Jung1, Juliane Bremer, Johannes Streffer, Kanwar Virdee, Maria Grazia Spillantini, R Anthony Crowther, Peter Brugger, Christine Van Broeckhoven, Adriano Aguzzi, Markus Tolnay.   

Abstract

Neurodegenerative tauopathies may be inherited as autosomal-dominant disorders with variable clinicopathological phenotypes, and causative mutations in the microtubule-associated protein tau (MAPT) gene are not regularly seen. Herein, we describe a patient with clinically typical and autopsy-proven corticobasal degeneration (CBD). Her mother was diagnosed to have Parkinson's disease, but autopsy showed CBD pathology as in the index patient. The sister of the index patient had the clinical symptoms of primary progressive aphasia (PPA), but no pathology was available to date. Molecular analysis did not reveal any mutation in the MAPT or progranulin (GRN) genes. Our findings illustrate that CBD, progressive supranuclear palsy and PPA may be overlapping diseases with a common pathological basis rather than distinct entities. Clinical presentation and course might be determined by additional, yet unknown, genetic modifying factors.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22261560      PMCID: PMC3638994          DOI: 10.1159/000334731

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  34 in total

1.  Dementia as the most common presentation of cortical-basal ganglionic degeneration.

Authors:  D A Grimes; A E Lang; C B Bergeron
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

2.  Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.

Authors:  Paul J Tuite; H Brent Clark; Catherine Bergeron; Matthew Bower; Peter St George-Hyslop; Vesselina Mateva; John Anderson; David S Knopman
Journal:  Arch Neurol       Date:  2005-09

3.  A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.

Authors:  Raquel Ros; Stéphane Thobois; Nathalie Streichenberger; Nicolas Kopp; Marina P Sánchez; Mar Pérez; Janet Hoenicka; Jesús Avila; Jerome Honnorat; Justo G de Yébenes
Journal:  Arch Neurol       Date:  2005-09

4.  Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

Authors:  P M Stanford; G M Halliday; W S Brooks; J B Kwok; C E Storey; H Creasey; J G Morris; M J Fulham; P R Schofield
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

5.  Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.

Authors:  H R Morris; R Katzenschlager; J C Janssen; J M Brown; M Ozansoy; N Quinn; T Revesz; M N Rossor; S E Daniel; N W Wood; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

6.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

Authors:  K A Josephs; R C Petersen; D S Knopman; B F Boeve; J L Whitwell; J R Duffy; J E Parisi; D W Dickson
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

Review 7.  Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.

Authors:  Markus Tolnay; Florence Clavaguera
Journal:  Neuropathology       Date:  2004-12       Impact factor: 1.906

Review 8.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.

Authors:  David R Williams; Andrew J Lees
Journal:  Lancet Neurol       Date:  2009-03       Impact factor: 44.182

Review 9.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

10.  Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

Authors:  M Goedert; M G Spillantini; N J Cairns; R A Crowther
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

View more
  6 in total

1.  Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Authors:  Emilia M Gatto; Ricardo F Allegri; Gustavo Da Prat; Patricio Chrem Mendez; David S Hanna; Michael O Dorschner; Ezequiel I Surace; Cyrus P Zabetian; Ignacio F Mata
Journal:  Neurobiol Aging       Date:  2017-02-10       Impact factor: 4.673

2.  A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.

Authors:  Shinsuke Fujioka; Bradley F Boeve; Joseph E Parisi; Pawel Tacik; Naoya Aoki; Audrey J Strongosky; Matt Baker; Monica Sanchez-Contreras; Owen A Ross; Rosa Rademakers; Vesna Sossi; Dennis W Dickson; A Jon Stoessl; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-08-19       Impact factor: 4.891

3.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

Review 4.  Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Authors:  Federica Arienti; Giulia Lazzeri; Maria Vizziello; Edoardo Monfrini; Nereo Bresolin; Maria Cristina Saetti; Marina Picillo; Giulia Franco; Alessio Di Fonzo
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

5.  Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.

Authors:  Helen Ling; Eleanna Kara; Tamas Revesz; Andrew J Lees; Gordon T Plant; Davide Martino; Henry Houlden; John Hardy; Janice L Holton
Journal:  Acta Neuropathol Commun       Date:  2014-02-21       Impact factor: 7.801

6.  MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han population.

Authors:  Pu Fang; Wenyuan Xu; Chengsi Wu; Min Zhu; Xiaobing Li; Daojun Hong
Journal:  Neural Regen Res       Date:  2013-11-25       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.